Corton Capital’s Compugen CGEN Stock Holding History

Corton Capital’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,783	Closed	-$41K	–	352
2022 Q1	$41K	Buy	+12,783	New	+$43.2K	0.02%	418

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Corton Capital's CGEN Position: Q2 2022 in Review

Corton Capital sold out of Compugen (CGEN) in Q2 2022, closing a stake of 12,783 shares — an estimated $41K sold.

Corton Capital first reported a position in CGEN in Q1 2022 and held it in 1 quarter. The position peaked at $41K in Q1 2022. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

Corton Capital reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
Corton Capital sold 12,783 Compugen shares in Q2 2022, an estimated $41K.
Corton Capital first reported a position in Compugen in Q1 2022 and held it in 1 quarter.
Corton Capital's Compugen position peaked at $41K in Q1 2022.
89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on Corton Capital's 13F filing for Q2 2022, filed 15 Aug 2022.